Wolters Kluwer Health has announced that its Sentri7® clinical surveillance solution has been named the Best in KLAS for infection control and monitoring in the 2025 Best in KLAS – Software and Services report. This marks the third time in four years that Sentri7 has earned this prestigious recognition from KLAS Research, a trusted leader in tracking and reporting the performance of healthcare technology providers.
KLAS Research conducts extensive interviews with thousands of healthcare professionals to evaluate the performance of software and services. The survey covers a range of criteria, including Culture, Loyalty, Operations, Product Features, Relationship, and Value. Sentri7 earned top marks in several categories, thanks to its ability to automate compliance workflows and save infection preventionists valuable time.
In today’s healthcare environment, hospitals and health systems continue to face difficulties in identifying at-risk populations and optimizing infection prevention programs. Sentri7 addresses these issues by automating infection control workflows, improving regulatory reporting, and continuously updating its features to meet new requirements, such as the 2024 changes to the National Healthcare Safety Network (NHSN) HRD guidelines.
Sentri7's ability to proactively identify infections, streamline workflows, and ensure compliance with regulatory standards has made it an invaluable tool for infection prevention teams. The solution is backed by a team of expert infection preventionists who provide ongoing support and ensure the system remains responsive to the evolving needs of healthcare providers.
The Best in KLAS designation highlights Sentri7’s operational and clinical impact on healthcare organizations, cementing its status as a market leader in clinical surveillance. The award serves as a testament to Wolters Kluwer’s continued commitment to supporting healthcare professionals in delivering superior patient care.
Click here to read the original press release.
